Webinar | November 12, 2024
Moving Multi-Omics Beyond the Genome: Next-Gen Approaches to Amplify Drug Development Insights
Get the Resource
Oxford Global Multi-Omics Symposium - Presentation - November 12, 2024
"*" indicates required fields
Sapient recently participated in the Multi-Omics in Biomarker Discovery & Precision Medicine Online Symposium, hosted by Oxford Global. This exciting event brought together scientific and technological innovators for focused conversations on multi-omics advancements in drug development. From individual presentations to collaborative panel discussions, it was a chance to hear from delegates across pharma, biotech, and academia on how they are leveraging multiomics (proteomics, metabolomics, and transcriptomics) technologies and techniques to amplify biomarker discovery and toward the development of precision medicines.
Sapient's Featured Session
"Moving Multi-Omics Beyond the Genome: Next-Gen Approaches to Amplify Drug Development Insights"
Sapient’s Chief Business Officer, Dr. Jonathan Usuka, discusses:
- The need for dynamic biomarkers – metabolites, lipids, and proteins – to complement genomics data and enable greater understanding of disease mechanisms and drug response over time
- How next-generation approaches, including high throughput mass spectrometry and advanced AI/ML tools, now enable efficient multi-omics interrogation ‘beyond the genome’ for greater insight generation
- Real-world examples of how multiomics (proteomics, metabolomics, transcriptomics) approaches are being applied in drug discovery and development programs today – from early target identification to high throughput drug screening, preclinical studies, and clinical trials – to accelerate precision medicines
Complete the form to access the full video of this session!
During the symposium, Dr. Usuka also joined expert panelists from Boehringer Ingelheim, The Institute of Cancer Research, London, Arizona State University, and SciLifeLab to share best practices for implementation and harmonization of various multi-omics datasets. You can access this discussion and additional presentations on:
- Inflammatory Disease Biomarker Development Using Omics Approaches
- Next-Generation Multi-Omics to Amplify Drug Development Insights
- Single Cell Spatial Proteomic & Transcriptomics
- Multimodal Analysis Towards Biomarker Complexity
Register here for on-demand access to the full symposium!
Get the Resource
Oxford Global Multi-Omics Symposium - Presentation - November 12, 2024
"*" indicates required fields
